(Q24240567)

26 October 2023

John K Marshall

1

John K

Marshall

1 reference

26 October 2023

Marroon Thabane

2

Marroon

Thabane

1 reference

26 October 2023

Jamie R Newman

4

Jamie R

Newman

1 reference

26 October 2023

Anju Anand

5

Anju

Anand

1 reference

26 October 2023

E Jan Irvine

6

E Jan

Irvine

1 reference

Cochrane Database of Systematic Reviews

26 October 2023

language of work or name

1 reference

20 January 2010

0 references

published in

0 references

cites work

Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Better quality of therapy with 5-ASA colonic foam in active ulcerative colitis. A multicenter comparative trial with 5-ASA enema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

A new mesalazine foam enema (Claversal Foam) compared with a standard liquid enema in patients with active distal ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

A new oral delivery system for 5-ASA: preliminary clinical findings for MMx.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Short-chain fatty acid enemas: a cost-effective alternative in the treatment of nonspecific proctosigmoiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Long-term use of mesalamine enemas to induce remission in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Proctocolitis unresponsive to conventional therapy. Response to 5-aminosalicylic acid enemas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Comparison of bismuth citrate and 5-aminosalicylic acid enemas in distal ulcerative colitis: a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Rectal corticosteroids versus alternative treatments in ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Microscopic activity in ulcerative colitis: what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Biopsy studies in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

Effect of weekend 5-aminosalicylic acid (mesalazine) enema as maintenance therapy for ulcerative colitis: results from a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Topical treatment with 5-aminosalicylic in distal ulcerative colitis by using a new suppository preparation. A double-blind placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Correlations between defined sigmoidoscopic appearances and other measures of disease activity in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Efficacy of 5-aminosalicylic acid enemas versus hydrocortisone enemas in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc-labeled 5-ASA suppositories

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Serial rectal biopsy in ulcerative colitis during the course of a controlled therapeutic trial of various diets

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

5-Aminosalicylic acid suppositories in the management of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid enemas

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

A new mesalazine gel enema in the treatment of left-sided ulcerative colitis: a randomized controlled multicentre trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Efficacy and tolerability of mesalazine foam enema (Salofalk foam) for distal ulcerative colitis: a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Therapeutic Efficacy of Sulfasalazine and Its Metabolites in Patients with Ulcerative Colitis and Crohn's Disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

5-ASA enemas for refractory distal ulcerative colitis. An open trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Comparison of beclomethasone dipropionate and prednisolone 21-phosphate enemas in the treatment of ulcerative proctitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

5-Aminosalicylic Acid as Enemas or Suppositories in Distal Ulcerative Colitis?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Beclomethasone dipropionate (3 mg) versus 5-aminosalicylic acid (2 g) versus the combination of both (3 mg/2 g) as retention enemas in active ulcerative proctitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Distribution of mesalazine enemas in active and quiescent ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Rectal aminosalicylate therapy for distal ulcerative colitis: a meta‐analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Sulphasalazine rectal enemas: topical method of inducing remission of active ulcerative colitis affecting rectum and descending colon

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Sulphasalazine retention enemas in ulcerative colitis: a double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

A defence of the small clinical trial: evaluation of three gastroenterological studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

A double-blind clinical trial to compare the effects of 4-aminosalicylic acid to 5-aminosalicylic acid in topical treatment of ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

The effect of topical N-acetyl-5-aminosalicylic acid in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Histologic and colonoscopic assessment of disease extension in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021

Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004115.PUB2

7 January 2021